1. Home
  2. FEMY vs MDRR Comparison

FEMY vs MDRR Comparison

Compare FEMY & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.38

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

MDRR

Medalist Diversified REIT Inc.

N/A

Current Price

$11.27

Market Cap

18.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
MDRR
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
18.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FEMY
MDRR
Price
$0.38
$11.27
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.0M
1.2K
Earning Date
05-08-2026
03-02-2026
Dividend Yield
N/A
2.43%
EPS Growth
44.71
N/A
EPS
N/A
N/A
Revenue
$2,293,313.00
N/A
Revenue This Year
$105.16
N/A
Revenue Next Year
$200.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.77
N/A
52 Week Low
$0.31
$9.47
52 Week High
$1.11
$14.52

Technical Indicators

Market Signals
Indicator
FEMY
MDRR
Relative Strength Index (RSI) 46.47 50.04
Support Level $0.34 $11.00
Resistance Level $0.46 $11.91
Average True Range (ATR) 0.04 0.26
MACD 0.00 -0.02
Stochastic Oscillator 24.29 77.20

Price Performance

Historical Comparison
FEMY
MDRR

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

Share on Social Networks: